Silvia Cavalli
Overview
Explore the profile of Silvia Cavalli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cavalli S, DAmario C, Giupponi M, Icardi G, Isola S, Montefiori M
J Prev Med Hyg
. 2025 Jan;
65(3):E309-E311.
PMID: 39758771
No abstract available.
2.
Elli S, Cavalli S, Fantini V, Fragapane M, Salvoldi N, Zappa P, et al.
J Vasc Access
. 2024 Oct;
:11297298241292218.
PMID: 39449128
Introduction: Peripherally Inserted Central Catheters and Midline Catheters are particularly attractive because of their favorable risk/benefit ratio. If the ideal venipuncture site is in an area inappropriate for catheter emergence,...
3.
Papa N, Cavalli S, Rindone A, Onida F, Saporiti G, Minniti A, et al.
Arthritis Res Ther
. 2024 Oct;
26(1):182.
PMID: 39444017
Background: Autologous haematopoietic stem cell transplantation (AHSCT) is more effective than conventional immunosuppressive therapies (CIT) in improving the outcome of patients with rapidly progressive diffuse cutaneous systemic sclerosis (dcSSc). So...
4.
De Lorenzis E, Natalello G, Pellegrino G, Verardi L, Batani V, Lepri G, et al.
Rheumatology (Oxford)
. 2024 Sep;
PMID: 39348184
Background: Mycophenolate mofetil (MMF) is a mainstay for the treatment of systemic sclerosis (SSc). The occurrence and implications of MMF-related adverse events on drug retention rates in real life remain...
5.
Iannone C, Pellico M, Morlacchi L, Rossetti V, Vicenzi M, Beretta L, et al.
Rheumatology (Oxford)
. 2024 Sep;
PMID: 39298492
Objectives: Lung transplantation (LuTx) is a life-saving intervention for Systemic Sclerosis (SSc) patients with end-stage lung disease. The aim of this study was to evaluate patients' survival and LuTx outcomes...
6.
Luca G, De Lorenzis E, Campochiaro C, Cacciapaglia F, Papa N, Zanatta E, et al.
Rheumatology (Oxford)
. 2024 May;
64(3):1284-1291.
PMID: 38745439
Objectives: To report real-life data on rituximab retention rate as an indicator of safety and efficacy in a multicentric national cohort of systemic sclerosis patients. Methods: SSc patients treated with...
7.
Giustivi D, Donadoni M, Elli S, Casella F, Quici M, Cogliati C, et al.
Nurs Rep
. 2024 Feb;
14(1):455-467.
PMID: 38391080
Introduction: Situations involving increased workloads and stress (i.e., the COVID-19 pandemic) underline the need for healthcare professionals to minimize patient complications. In the field of vascular access, tunneling techniques are...
8.
De Vito R, Fiori F, Ferraroni M, Cavalli S, Caporali R, Ingegnoli F, et al.
Nutrients
. 2023 Feb;
15(4).
PMID: 36839323
Few observational studies investigated the relationship between single food groups and disease activity in rheumatoid arthritis (RA). Within a recent Italian cross-sectional study (365 patients, median age: 58.46 years, 78.63%...
9.
Ingegnoli F, Cavalli S, Giudice L, Caporali R
Autoimmun Rev
. 2022 May;
21(7):103117.
PMID: 35595049
The current ideal goal of rheumatoid arthritis (RA) management is to resolve joint and systemic inflammation by using pharmacological interventions, assuming this will correspondingly lead to overall well-being. Nonetheless, it...
10.
Cavalli S, Lonati P, Gerosa M, Caporali R, Cimaz R, Chighizola C
Front Pharmacol
. 2022 Mar;
13:841785.
PMID: 35242041
Evidence about the relevance of the complement system, a highly conserved constituent of the innate immunity response that orchestrates the elimination of pathogens and the inflammatory processes, has been recently...